Compounds > 1,4,7-triazacyclononane-n,n',n''-triacetic acid
Page last updated: 2024-09-03

1,4,7-triazacyclononane-n,n',n''-triacetic acid and Signet Ring Cell Carcinoma

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Signet Ring Cell Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Guo, YH; Yang, MF1

Other Studies

1 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Signet Ring Cell Carcinoma

ArticleYear
Comparison of 18F-AlF-NOTA-FAPI and 18F-FDG Imaging in a Patient With Gastric Signet-Ring Cell Carcinoma.
    Clinical nuclear medicine, 2021, Nov-01, Volume: 46, Issue:11

    Topics: Carcinoma, Signet Ring Cell; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Humans; Positron Emission Tomography Computed Tomography; Quinolines

2021